MIR8080: A Potential Drug Target and Biomarker for Cancer (G102465877)
MIR8080: A Potential Drug Target and Biomarker for Cancer
MicroRNA (miRNA) 8080 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. MIR8080 is a part of the miRNA-21 (miR-21) family, which consists of 21 non-coding RNAs that have been shown to play important roles in various biological processes.
The miR-21 family of RNAs is characterized by the presence of a specific stem-loop structure, which is composed of a series of alternating A/U and G/C base pairs. This structure is present in all members of the miR-21 family, including MIR8080. MIR8080 has a length of 20 amino acids and a calculated molecular weight of 19.95 kDa.
MIR8080 has been shown to regulate various cellular processes, including cell growth, apoptosis (programmed cell death), and inflammation. It has been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that MIR8080 is downregulated in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, MIR8080 has been shown to be involved in the regulation of cellular apoptosis, which is the process by which cells undergo programmed cell death.
MIR8080 has also been shown to be involved in the regulation of various signaling pathways, including the NF-kappa pathway. NF-kappa is a well-known signaling pathway that is involved in the regulation of cell growth, differentiation, and apoptosis. MIR8080 has been shown to play a role in the regulation of NF-kappa signaling by negative inhibition. This means that MIR8080 appears to act as a negative regulator of NF-kappa, which can inhibit its effects on cellular processes.
In addition to its role in cellular signaling pathways, MIR8080 has also been shown to be involved in the regulation of gene expression. Studies have shown that MIR8080 can interact with various gene expression factors, including miRNA-21, to regulate their activity. This means that MIR8080 can act as a negative regulator of miRNA-21, which can inhibit its effects on gene expression.
MIR8080 has also been shown to be involved in the regulation of cellular transport processes. Studies have shown that MIR8080 can interact with various transport proteins, including the protein TRPV4, to regulate its activity. This means that MIR8080 can act as a negative regulator of TRPV4, which can inhibit its effects on cellular transport processes.
In conclusion, MIR8080 is a non-coding RNA molecule that has been shown to play important roles in various cellular processes, including cell growth, apoptosis, and inflammation. Its role in these processes makes it a potential drug target and biomarker for various diseases, including cancer. Further research is needed to fully understand the mechanisms of MIR8080's role in cellular processes and its potential as a drug.
Protein Name: MicroRNA 8080
The "MIR8080 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR8080 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A | MIR99AHG | MIR99B | MIRLET7 | MIRLET7A1 | MIRLET7A2 | MIRLET7A3 | MIRLET7B | MIRLET7BHG | MIRLET7C | MIRLET7D | MIRLET7E | MIRLET7F1 | MIRLET7F2 | MIRLET7G | MIRLET7I | MIS12 | MIS12 complex | MIS18A | MIS18A-AS1 | MIS18BP1 | MISFA | MISP | MISP3 | MITD1 | MITF | Mitochondrial complex I assembly complex | Mitochondrial import inner membrane translocase 23 (TIM23) complex | Mitochondrial inner membrane protease complex | Mitochondrial membrane ATP synthase | Mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) | Mitochondrial pyruvate carrier complex (MPC) | Mitochondrial RNA processing endoribonuclease | Mitofilin Complex | Mitofusin | Mitogen-Activated Protein Kinase | Mitogen-activated protein kinase (JNK) | Mitogen-Activated Protein Kinase (MAP Kinase)-Activated Protein Kinase | Mitogen-Activated Protein Kinase Kinase Kinase (MAP3K) | Mitogen-activated protein kinase p38 (MAPK p38) | MITRAC complex | MIX23 | MIXL1 | MKI67 | MKKS
